Related Experiment Videos

Developmentally regulated promoters from Dictyostelium discoideum as molecular markers for testing potential

J Tillner1, T Winckler, T Dingermann

  • 1Institut für Pharmazeutische Biologie, Johann Wolfgang Goethe-Universität, Frankfurt, Germany.

Die Pharmazie
|November 1, 1996
PubMed

Insights

Dictyostellium discoideum offers a novel system for assessing drug developmental toxicity. This study demonstrates its utility in detecting teratogenic effects, using valproic acid as a model compound.

Area of Science:

  • Developmental Biology
  • Toxicology
  • Biotechnology

Background:

  • Early toxicological testing is crucial for pharmaceutical development.
  • Estimating teratogenic potential is a key aspect of drug safety assessment.
  • Dictyostellium discoideum has shown promise as a model for cytotoxicity testing.

Purpose of the Study:

  • To establish a Dictyostellium discoideum-based test system for predicting drug interference with developmental programs.
  • To detect and quantify the effects of potential teratogens on D. discoideum development.
  • To evaluate the known teratogen valproic acid (VPA) using this novel system.

Main Methods:

  • Development of a D. discoideum-based assay using transgenic strains.
  • Each strain contains a bacterial lacZ gene under a specific developmentally regulated promoter.
  • Quantification of teratogenic effects based on reporter gene expression during development.

Main Results:

  • The study successfully established a method to detect and quantify teratogenic effects in D. discoideum.
  • Valproic acid (VPA), a known teratogen, demonstrated measurable effects on the D. discoideum developmental system.
  • The system showed sensitivity to the known teratogenic compound.

Conclusions:

  • Dictyostellium discoideum provides a viable model for assessing the developmental toxicity of chemical compounds.
  • This D. discoideum-based system can predict potential teratogenic effects of drugs.
  • The established method offers a new tool for early-stage drug safety evaluation.

Related Concept Videos